SHD

$38.879 Billion Heart Failure Devices Markets - Global Forecast to 2029 - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 20, 2023

The "Heart Failure Devices Global Market - Forecast To 2029" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Heart Failure Devices Global Market - Forecast To 2029" report has been added to ResearchAndMarkets.com's offering.
  • The heart failure devices global market expected to grow at high single-digit CAGR from 2022 to 2029 to reach $38,879.9 million by 2029.
  • Factors such as increasing incidence of heart failure diseases, technological advancement in heart failure devices, rising geriatric population, and favorable reimbursement are the drivers, vast pipeline products, increase in funding and approvals are the opportunities.
  • The heart failure devices market based on products is segmented as cardiac rhythm products, cardiac assist devices (CAD), structural heart devices (SHD), ECMO and others (modulation devices).

Harris Williams Advises Bregal in Connection with the Combination of Four Portfolio Companies to Form GENII Software Group

Retrieved on: 
Friday, November 18, 2022

Harris Williams, a global investment bank specializing in M&A advisory services, announces it advised Bregal Unternehmerkapital Funds (Bregal) in connection with the combination of four portfolio companies, GUS Group (GUS), iptor, SHD, and PDV, to form GENII Software Group (GENII).

Key Points: 
  • Harris Williams, a global investment bank specializing in M&A advisory services, announces it advised Bregal Unternehmerkapital Funds (Bregal) in connection with the combination of four portfolio companies, GUS Group (GUS), iptor, SHD, and PDV, to form GENII Software Group (GENII).
  • The transaction was led by the Harris Williams Technology Group, including Thierry Monjauze, Mathew Tsui , Christopher Duerolf, and Ruben Pinheiro.
  • We look forward to following the continued success of the new GENII banner, said Thierry Monjauze, a managing director at Harris Williams.
  • Harris Williams is a trade name under which Harris Williams LLC, Harris Williams & Co. Ltd and Harris Williams & Co. Corporate Finance Advisors GmbH conduct business.

Tempus Launches First Cardiology Prospective Study for Its AI-Enabled Predictive Tests

Retrieved on: 
Thursday, November 3, 2022

The study investigates whether layering a machine learning model onto a clinically acquired electrocardiogram (ECG) can make it smarter with new functionality.

Key Points: 
  • The study investigates whether layering a machine learning model onto a clinically acquired electrocardiogram (ECG) can make it smarter with new functionality.
  • Millions of Americans suffer from undiagnosed heart disease, leading to debilitating outcomes, such as stroke, that can potentially be avoided with early diagnosis.
  • Tempus AI-enabled technology aims to help clinicians find these patients.
  • Patients who have received a 12-lead ECG during routine clinical care are eligible for the study.

National Association of Chronic Disease Directors and Health Promotion Council Launch Media Campaign Promoting the Use of Text Messaging to Prevent Type 2 Diabetes Among Pennsylvanians

Retrieved on: 
Wednesday, August 24, 2022

PHILADELPHIA and PROVIDENCE, R.I., Aug. 24, 2022 /PRNewswire/ -- To address the public health crisis of skyrocketing diabetes among Black and Hispanic Pennsylvanians who develop diabetes at greater prevalence, the Health Promotion Council (HPC) and the National Association of Chronic Disease Directors (NACDD) have joined forces to launch "Make a Choice for a Healthier Life" campaign. More than one million households in Pennsylvania are being engaged through this multi-channel campaign, led by multicultural marketing firm Perry Media Group (PMG) and powered by the global health and wellbeing engagement leader, Virgin Pulse.

Key Points: 
  • Participants who screen high will be referred to a Centers for Disease Control and Prevention (CDC)-led National Diabetes Prevention Program (National DPP) in their area.
  • "It's critical that we help Pennsylvanians know if they are at risk for developing type 2 diabetes.
  • Type 2 diabetes is a significant health issue in the U.S., particularly among Black and Hispanic populations.
  • [iii] Recognizing the need to address this growing health threat, CDC established the National DPP to reduce the impact of prediabetes and type 2 diabetes.

Update on Sale of Lomiko Technologies Inc. to Promethieus Technologies Inc. For $ 1,236,625

Retrieved on: 
Tuesday, October 5, 2021

Subsequent to news releases issued by Lomiko on July 31, 2019 , Dec. 3, 2019 , and Aug. 6, 2020 , Lomiko confirmed its has entered into and extended its sale agreement of Lomiko Technologies to Promethieus Technologies as of October 4, 2021 to November 30, 2022.

Key Points: 
  • Subsequent to news releases issued by Lomiko on July 31, 2019 , Dec. 3, 2019 , and Aug. 6, 2020 , Lomiko confirmed its has entered into and extended its sale agreement of Lomiko Technologies to Promethieus Technologies as of October 4, 2021 to November 30, 2022.
  • Upon completion of the sale, Lomiko Metals will receive $1,236,625 and $152,857 in expenses paid on behalf of Promethieus by Lomiko Metals.
  • Promethieus Technologies has informed Lomiko that it has entered into an agreement to purchase 40% of Graphene ESD for $ 10,000 USD.
  • Therefore, upon completion of the Lomiko Technologies purchase, Promethieus will own 80% interest in Graphene ESD.